When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

TJ Bio has reportedly submitted a biologics license application (BLA) to China’s Center for Drug Evaluation for GX-H9 ...

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower deal values, ...

Ziltivekimab is under clinical development by Novo Nordisk and currently in Phase III for Myocardial Infarction.

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

INR:3284. rummy wheels 2 Pharmaceutical companies cancel their drug production licenses Novo Nordisk's Sogroya gets FDA approval: first growth hormone for once-weekl ...

This policy may affect all machinery companies Novo Nordisk's Sogroya gets FDA approval: first growth hormone for once-weekly subcutaneous injection ORR up to 59%! Phase Ib trial data of PD-1 antibody ...

INR:4030. rummy today app These drugs are no longer sold in hospitals (list attached) Novo Nordisk's Sogroya gets FDA approval: first growth hormone for once-week ...

Subcutaneous injection of growth hormone once a week! Novo Nordisk's Sogroya is recommended by the EU CHMP The risk of ...

INR:1292. game bataiye A number of drug companies have withdrawn from the market Remdesivir generic drug approved and priced Novo Nordisk's once-weekly long-acting g ...